C3.ai Founder Thomas Siebel Sells $7.6 Million in Stock After Difficult Year

Thomas Siebel sold 532,832 C3.ai shares across Dec. 16-17, 2025 via indirect entities (chiefly The Siebel Living Trust) for a weighted average price of $14.33, generating roughly $7.6 million in proceeds under a pre-arranged plan. Post-transaction, Siebel retains 722,362 direct shares and 2,431,165 indirect shares; the company has a market cap of ~$1.96 billion and TTM revenue of $352.9 million, with fiscal Q2 revenue of $75.1 million (up 7% sequentially) but remains deeply unprofitable. The sale is consistent with a series of dispositions since March 2025 (18 sell trades, median ~538k shares) that have reduced his holdings by ~91% (~7.3 million shares), while C3.ai shares are down ~58.8% over the prior year, signaling continued investor caution despite federal contract momentum and management transition. Investors should weigh the signaling effect of repeated insider disposals against improving top-line trends and execution risks before repositioning.

Analysis

Market structure: Siebel’s ~532k-share indirect sale (~$7.6M) is economically immaterial to C3.ai’s ~136M‑share base (~0.4% of float) but signals continued founder monetization amid a 58.8% YTD price decline. Short-term winners are large, integrated cloud/software incumbents (e.g., ORCL, AWS partners) that benefit from risk‑averse enterprise buyers; small‑cap pure‑play AI vendors lose relative pricing power as buyers consolidate with proven vendors. Cross‑asset: expect elevated IV in AI single‑name options for 2–8 weeks, little direct FX/commodity impact, and modest widening of credit spreads for speculative tech issuers if sentiment deteriorates further.

Risk assessment: Tail risks (6–18 months) include a forced capital raise that dilutes equity (>10% issuance), material federal contract loss, or adverse AI regulation reducing addressable market by >20%. Immediate (days) impact is technical; short term (weeks–months) depends on Q3/Q4 bookings and CEO execution; long term (12–36 months) hinges on margin expansion and SaaS gross retention improving to >85%. Hidden dependencies: concentration in federal revenue and partner stack (Oracle/AWS) that can amplify downside if partners reprice or re‑platform workloads.

Trade implications: Favor size‑constrained, asymmetric exposures: a modest directional conviction in AI (ticker AI) only with downside protection — targeted 1–3% NAV equivalent. Use options to define risk: buy 12‑month 15C/30C call spreads to cap risk with a 40–60% upside target, or buy 3‑month 12.5P as cheap tail hedges. Rotationally, trim speculative AI/big‑data small caps and redeploy 2–4% into ORCL (defensive enterprise AI exposure) and selective cloud leaders.

Contrarian angles: The market may have over‑punished AI relative to stabilization signs (Q2 rev +7% sequential). Insider sales were via pre‑arranged trust and follow a steady cadence; declining insider capacity (–91% since March) reduces future dump risk. If next two quarters show sequential revenue growth ≥3% and improving gross margins (+300bps), upside could be underpriced—prepare to scale longs quickly between $12.6–$18; conversely, cut if revenue misses by >5% or cash runway <12 months.

Key Decisions for Investors

• Establish a tactical long in C3.ai (AI) sized 1–3% of NAV using defined‑risk options: buy Jan 2027 15C and sell Jan 2027 30C (call spread) to limit downside; target 40–60% upside within 9–15 months, max loss = premium paid.
• Buy a 3‑month protective 12.5P for ~0.5% NAV (or equivalent) to cap near‑term downside; liquidate that put if AI closes >$16 for 5 consecutive trading days.
• Rotate 2–4% of speculative AI/small‑cap tech exposure into ORCL (buy shares or 6–12 month call spreads) as defensive enterprise AI/cloud exposure; allocate if AI portfolio volatility >30% realized over 30 days.
• If AI reports two consecutive quarters with revenue growth ≥3% QoQ and gross margin improvement ≥300bps, scale long position to 5% NAV; if revenue misses by >5% or company signals cash runway <12 months, reduce AI exposure to zero and exit options.
• Short small, high‑multiple pure‑play AI peers (size 0.5–1% NAV) that show negative free cash flow and no federal revenue diversification; target pairs where AI has federal revenue tailwinds and peers do not (close positions after 6–12 months or if peers report 10%+ ARR growth).